熱門資訊> 正文
Edesa Biotech宣布350万美元PIPE融资
2026-06-11 21:45
- Edesa Biotech (Nasdaq: EDSA) on Thursday said it entered into a securities purchase agreement for a private investment in public equity financing expected to raise approximately $3.5 million in gross proceeds.
- The clinical-stage biopharmaceutical company said investors in the financing include its chief executive officer and healthcare-focused investors.
- The transaction is expected to close on or about June 15, subject to customary closing conditions.
- Under the PIPE, Edesa will sell 729,241 common shares at $4.69 per share to investors and at $5.21 per share to its chief executive officer.
- The company said it expects to use the net proceeds to advance its vitiligo program and drug candidate paridiprubart, as well as for working capital and general corporate purposes.
- Source: Press Release
More on Edesa Biotech
- Edesa Biotech, Inc. (EDSA) Presents at Dermatology Drug Development Summit 2026 - Slideshow
- Edesa Biotech, Inc. (EDSA) Presents at Respiratory Innovation Summit 2026 - Slideshow
- Edesa Biotech GAAP EPS of -$0.49
- Seeking Alpha’s Quant Rating on Edesa Biotech
- Historical earnings data for Edesa Biotech
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
